Patents by Inventor Ralph Raymond

Ralph Raymond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12565529
    Abstract: Provided herein are a method of treating type 1 diabetes (T1D). In some embodiments, such method can include administering to a subject in need thereof a 12-day course of teplizumab at a total dose of more than about 9000 ?g/m2.
    Type: Grant
    Filed: May 24, 2022
    Date of Patent: March 3, 2026
    Assignee: Provention Bio, Inc.
    Inventors: Francisco Leon, Ralph Raymond
  • Publication number: 20220380465
    Abstract: Provided herein are a method of treating type 1 diabetes (T1D). In some embodiments, such method can include administering to a subject in need thereof a 12-day course of teplizumab at a total dose of more than about 9000 ?g/m2.
    Type: Application
    Filed: May 24, 2022
    Publication date: December 1, 2022
    Applicant: Provention Bio, Inc.
    Inventors: Francisco Leon, Ralph Raymond